Antiparkinson Drugs

Antiparkinson Drugs



Antiparkinson drugs are medicines that relieve the symptoms of Parkinson's disease and other forms of parkinsonism.


Antiparkinson drugs are used to treat symptoms of parkinsonism, a group of disorders that share four main symptoms: tremor or trembling in the hands, arms, legs, jaw, and face; stiffness or rigidity of the arms, legs, and trunk; slowness of movement (bradykinesia); and poor balance and coordination. Parkinson's disease is the most common form of parkinsonism and is seen more frequently with advancing age. Other forms of the disorder may result from viral infections, environmental toxins, carbon monoxide poisoning, and the effects of treatment with antipsychotic drugs.
Antiparkinson Drugs
Brand Name (Generic
Possible Common Side Effects Include:
Artane (trihexyphenidyl
Dry mouth, nervousness, blurred vision,
Benadryl (diephenhydra-
mine hydrochloride)
Dizziness, sleepiness, upset stomach,
decreased coordination
Cogentin (benztropine
Constipation, dry mouth, nausea and
vomiting, rash
Eldepryl (selegiline
Abdominal and back pain, drowsiness,
decreased coordination
Parlodel (bromocriptine
Constipation, decreased blood pressure,
abdominal cramps
Sinemet CR Involuntary body movements, confusion,
nausea, hallucinations
The immediate cause of Parkinson's disease or Parkinsonian-like syndrome is the lack of the neurotransmitter dopamine in the brain. Drug therapy may take several forms, including replacement of dopamine, inhibition of dopamine metabolism to increase the effects of the dopamine already present, or sensitization of dopamine receptors. Drugs may be used singly or in combination.


Levodopa (Larodopa) is the mainstay of Parkinson's treatment. The drug crosses the blood-brain barrier, and is converted to dopamine. The drug may be administered alone, or in combination with carbidopa (Lodosyn) which inhibits the enzyme responsible for the destruction of levodopa. The limitation of levodopa or levodopa-carbidopa therapy is that after approximately two years of treatment, the drugs cease to work reliably. This has been termed the "on-off phenomenon." Additional treatment strategies have been developed to retard the progression of Parkinsonism, or to find alternative approaches to treatment.
Anticholinergic drugs reduce some of the symptoms of Parkinsonism, and reduce the reuptake of dopamine, thereby sustaining the activity of the natural neurohormone. They may be effective in all stages of the disease. All drugs with anticholinergic properties, the naturally occurring belladonna alkaloids (atropine, scopolamine, hyoscyamine), some antihistamines with anticholinergic properties, and synthetics such as benztropin (Cogentin), procyclidine (Kemadrin) and biperiden (Akineton) are members of this group. Although the anticholinergic drugs have only limited activity against Parkinson's disease, they are useful in the early stages, and may be adjuncts to levodopa as the disease progresses.
Amantadine (Symmetrel), was developed for prevention of influenza virus infection, but has anti-Parkinsonian properties. Its mechanism of action is not known.
Bromocriptine (Parlodel) is a prolactin inhibitor, which is used for a variety of indications including amenorrhea/galactorrhea, female infertility, and acromegaly. It appears to work by direct stimulation of the dopamine receptors. Bromocriptine is used as a late adjunct to levodopa therapy, and may permit reduction in levodopa dosage. Pergolide (Permax) is similar to bromocriptine, but has not been studied as extensively in Parkinson's disease.
Entacapone (Comtan) appears to act by maintaining levels of dopamine through enzyme inhibition. It is used as an adjunct to levodopa was the patient is beginning to experience the on-off effect. Tolcapone (Tasmar) is a similar agent, but has demonstrated the potential for inducing severe liver failure. As such, tolcapone is reserved for cases where all other adjunctive therapies have failed or are contraindicated.
Selegeline (Carbex, Eldepryl) is a selective monoamine oxidase B (MAO-B) inhibitor, however its mechanism of action in Parkinsonism is unclear, since other drugs with MAO-B inhibition have failed to show similar anti-Parkinsonian effects. Selegeline is used primarily as an adjunct to levodopa, although some studies have indicated that the drug may be useful in the early stages of Parkinsonism, and may delay the progression of the disease.
Pramipexole (Mirapex) and ropinirole (Requip) are believed to act by direct stimulation of the dopamine receptors in the brain. They may be used alone in early Parkison's disease, or as adjuncts to levodopa in advanced stages.

Recommended dosage

Dosages of anti-Parkinsonian medications must be highly individualized. All doses must be carefully titrated. Consult specific references.

Key terms

Anorexia — Lack or loss of appetite.
Anticholigerginc — An agent that blocks the parasympathetic nerves and their actions.
Bradykinesia — Extremely slow movement.
Bruxism — Compulsive grinding or clenching of the teeth, especially at night.
Carbon monoxide — A colorless, odorless, highly poisonous gas.
Central nervous system — The brain and spinal cord.
Chronic — A word used to describe a long-lasting condition. Chronic conditions often develop gradually and involve slow changes.
Hallucination — A false or distorted perception of objects, sounds, or events that seems real. Hallucinations usually result from drugs or mental disorders.
Heat stroke — A severe condition caused by prolonged exposure to high heat. Heat stroke interferes with the body's temperature regulating abilities and can lead to collapse and coma.
Parkinsonism — A group of conditions that all have these typical symptoms in common: tremor, rigidity, slow movement, and poor balance and coordination.
Pregnancy category — A system of classifying drugs according to their established risks for use during pregnancy. Category A: Controlled human studies have demonstrated no fetal risk. Category B: Animal studies indicate no fetal risk, but no human studies; or adverse effects in animals, but not in well-controlled human studies. Category C: No adequate human or animal studies; or adverse fetal effects in animal studies, but no available human data. Category D: Evidence of fetal risk, but benefits outweigh risks. Category X: Evidence of fetal risk. Risks outweigh any benefits.
Seizure — A sudden attack, spasm, or convulsion.
Spasm — Sudden, involuntary tensing of a muscle or a group of muscles.
Tremor — Shakiness or trembling.


There are a large number of drugs and drug classes used to treat Parkinson's disease, and individual references should be consulted.
The anticholinergics have a large number of adverse effects, all related to their primary mode of activity. Their cardiovascular effects include tachycardia, palpitations, hypotension, postural hypotension, and mild bradycardia. They may also cause a wide range of central nervous system effects, including disorientation, confusion, memory loss, hallucinations, psychoses, agitation, nervousness, delusions, delirium, paranoia, euphoria, excitement, lightheadedness, dizziness, headache, listlessness, depression, drowsiness, weakness, and giddiness. Dry mouth, dry eyes and gastrointestinal distress are common problems. Sedation has been reported with some drugs in this group, but this may be beneficial in patients who suffer from insomnia. Pregnancy risk factor is C. Because anticholinergic drugs may inhibit milk production, their use during breastfeeding is not recommended. Patients should be warned that anticholinergic medications will inhibit perspiration, and so exercise during periods of high temperature should be avoided.
Levodopa has a large number of adverse effects. Anorexia, loss of appetite, occurs in roughly half the patients using this drug. Symptoms of gastrointestinal upset, such as nausea and vomiting, have been reported in 80% of cases. Other reported effects include increased hand tremor; headache; dizziness; numbness; weakness and faintness; bruxism; confusion; insomnia; nightmares; hallucinations and delusions; agitation and anxiety; malaise; fatigue and euphoria. Levodopa has not been listed under the pregnancy risk factor schedules, but should be used with caution. Breastfeeding is not recommended.
Amantadine is generally well tolerated, but may cause dizziness and nausea. It is classified as pregnancy schedule C. Since amantadine is excreted in breast milk, breastfeeding while taking amantidine is not recommended.
Pergolide and bromocriptine have been generally well tolerated. Orthostatic hypotension are common problems, and patients must be instructed to risk slowly from bed. This problem can be minimized by low initial doses with small dose increments. Hallucinations may be a problem. Bromocriptine has not been evaluated for pregnancy risk, while pergolide is category B. Since both drugs may inhibit lactation, breastfeeding while taking these drugs is not recommended.
Pramipexole and ropinirole cause orthostatic hypotension, hallucinations and dizziness. The two drugs are in pregnancy category C. In animals, ropinirole has been shown to have adverse effects on embryo-fetal development, including teratogenic effects, decreased fetal body weight, increased fetal death and digital malformation. Because these drugs inhibit prolactin secretion, they should not be taken while breastfeeding.

Side effects

The most common side effects are associated with the central nervous system, and include dizziness, lightheadedness, mood changes and hallucinations. Gastrointestinal problems, including nausea and vomiting, are also common.


All anti-Parkinsonian regimens should be carefully reviewed for possible drug interactions. Note that combination therapy with anti-Parkinsonian drugs is, in itself, use of additive and potentiating interactions between drugs, and so careful dose adjustment is needed whenever a drug is added or withdrawn.
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.
References in periodicals archive ?
ANTIDEPRESSANT, UROLOGIC, and antiparkinson drugs with definite anticholinergic activity were associated with an increased risk of dementia as long as 20 years after exposure in a large observational study published in the BMJ.
When reduction of antiparkinson drugs does not improve psychotic symptoms, antipsychotic agents should be considered [10].
However, in a clinical study by Aarsland et al., no correlation between the prevalence of psychotic symptoms and the type, duration, and dose of antiparkinson drug therapy was found [13].
The serum RANTES and IL-6 levels showed no significant difference between subgroups of PD patients treated and not treated with antiparkinson drugs (Table 2).
Abuse of the antiparkinson drugs: a review of the literature.
(8,11) Patient outcomes can be optimized when anticholinergics are used in conjunction with levodopa or other antiparkinson drugs. (8) Patients with rigidity, mild cases of PD, or resting tremors typically derive the greatest benefit from use of anticholinergics.
Untreated depression hinders the patient's ability to appreciate benefit from antiparkinson drugs and disrupts family and healthcare team relationships.
Some PD patients were unable to have sex unless their antiparkinson drugs were working, and some partners felt that under these circumstances the drugs rather than emotion were driving desire.
The classic antihistamines can increase the CNS-depressant effects of various other drugs, such as MAOIs, tricyclic antidepressants, alcohol, antiparkinson drugs, barbiturates, tranquilizers, and narcotics.
Those who were cognitively impaired were more likely (p < 0.05) to take antidepressants, anti-emetics, anticonvulsants, neuroleptics, other sedative/hypnotics, and antiparkinson drugs than those who were cognitively intact.
Contrary to what patients may feel antiparkinson drugs don't stop working, nor do patients become "immune" to them.